Bone metastases: molecular mechanisms and novel therapeutic interventions. - Wikidata - wikimedia - TriplyDB

Bone metastases: molecular mechanisms and novel therapeutic interventions.

Bone metastases: molecular mechanisms and novel therapeutic interventions.

http://www.wikidata.org/entity/Q37785505

about

Slit/Robo pathway: a promising therapeutic target for cancer Hypoxic regulation of osteoclast differentiation and bone resorption activity Early growth response 4 is involved in cell proliferation of small cell lung cancer through transcriptional activation of its downstream genes Digital metastasis presenting as infection TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.Cathepsin B inhibition limits bone metastasis in breast cancer.Painful boney metastases.Myeloid-derived suppressor cells as osteoclast progenitors: a novel target for controlling osteolytic bone metastasis Deciphering signaling networks in osteosarcoma pathobiology.Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition Induction of thermal and mechanical hypersensitivity by parathyroid hormone-related peptide through upregulation of TRPV1 function and trafficking.Bone-targeted therapies for elderly patients with renal cell carcinoma: current and future directions.The physiopathological role of IL-33: new highlights in bone biology and a proposed role in periodontal disease.CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.Regulatory effect of chemokines in bone marrow niche.Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.Bone Pain and Muscle Weakness in Cancer Patients.Prostate cancer cells induce osteoblastic differentiation via semaphorin 3A.Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer.Multiple Roles of Angiopoietin-Like 4 in Osteolytic Disease Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.[Characteristics and treatment of bone metastases in 322 cases non-small cell lung cancer: a retrospective study].Parathyroid Hormone-Related Peptide Elicits Peripheral TRPV1-dependent Mechanical Hypersensitivity.Stromal cells in breast cancer as a potential therapeutic target.

P2860

Q27026113-B0BFE8E2-955D-434D-B3A2-7826345FC1CA Q28066276-DFA24635-E12D-4426-A1EF-683245CD6F5C Q34550071-DAAE1030-1CFB-4610-BFED-A366ED7CFD35 Q34981328-3AECF841-4275-486C-B6CB-642C1FB9345C Q35074030-0F1C7AAD-A70C-4A7F-BD7F-6FA0B77861B1 Q36511851-73ABF82A-E1FE-446E-8EB6-F07D9071FCED Q37011060-7207B441-2BEB-46CD-A376-1F23A2761502 Q37067495-F0D9CE95-475E-4E37-8492-B2B8D557FF13 Q37106930-CBC7D3FB-79F8-4006-99D9-6E4330FE05FD Q37169972-C1D0F210-5502-45A8-AFC5-98CA9467BC8E Q37351505-DC2E9BDC-23BE-427F-A2F7-60440AF2809F Q38144897-10DF5835-AC13-475B-B93A-57383E01289B Q38201456-18FA8F61-17D1-427C-862C-4E08C28EAB69 Q38209604-D478730E-5905-4CDD-AE94-FDA22C7C7168 Q38365227-300B031A-4E77-44BA-8A9C-C47016860BA9 Q38413261-D9C370A3-6EE9-4897-B72F-02993613B29D Q38684768-03684CFF-C301-4AA1-BFE0-C8F389AF6778 Q38938021-2D9FA7FE-1C13-47D9-A287-DB8695F7964B Q39138688-FAE15562-2314-47DD-8DE2-F49B15752ED5 Q39274312-E6C83BD4-6138-4607-AC70-9934EA70049C Q50026428-928E7C3D-A259-4D2A-8067-161FF9D03500 Q53049778-015B60A2-3D13-4FD1-97ED-A8B7C53D252F Q54982587-67F87EBC-AF10-4B6A-BA74-E5B6D72669A8 Q55016792-C36D80D7-5AF7-40B1-8ABF-F5955BB1DD26

P2860

Bone metastases: molecular mechanisms and novel therapeutic interventions.

http://www.wikidata.org/entity/Q37785505

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bone metastases: molecular mechanisms and novel therapeutic interventions.

@en

Bone metastases: molecular mechanisms and novel therapeutic interventions.

@nl

type

label

Bone metastases: molecular mechanisms and novel therapeutic interventions.

@en

Bone metastases: molecular mechanisms and novel therapeutic interventions.

@nl

prefLabel

Bone metastases: molecular mechanisms and novel therapeutic interventions.

@en

Bone metastases: molecular mechanisms and novel therapeutic interventions.

@nl

P1433

Q37785505-A278F281-9CAF-48A6-B860-28C1BB426FD7

P1476

Q37785505-44803BC0-6268-477C-92A3-0AA4F68D99FC

P2093

Q37785505-23932A0C-EB49-4E4A-BFB8-9CBD67314220

Q37785505-E1A15EEC-BF20-4066-A54F-AEA6EB1BF809

Q37785505-FA03E780-1954-4A7B-B40A-49837ADAFDCF

P2860

Q37785505-03FE8381-62F5-42B4-B5A5-007CD62F5B26

Q37785505-04F6B028-E862-4A8B-AE12-8D7ED4624C8D

Q37785505-07045443-C714-499D-BBF7-B3B0B0DD8184

Q37785505-079A3F92-79E2-4795-8BEE-43534734419C

Q37785505-0874C9CA-5F88-4B23-BF92-CC95F5536CEC

Q37785505-0903900B-F462-4A7D-BC6D-DCBC385FB364

Q37785505-0ADD1052-1442-4FC5-8A03-5B04BFAE2BEA

Q37785505-0C3AE8E4-54E9-4C5D-8541-7ABF805F77A6

Q37785505-0E5A55F6-287E-4ED7-AA76-02F94544D213

Q37785505-120663BE-0C1E-461A-BEEB-8D51D420F002

P304

Q37785505-EC0F9406-4733-41B9-BD1F-CB5BC15BEBA4

P31

Q37785505-4E105FF1-02BC-4697-A1D2-1FA66FA6E1A4

P356

Q37785505-B8698D4E-ED23-4CB4-B332-3613663DCC50

P433

Q37785505-97751360-F1F4-442F-A3E0-68C64968E5A1

P478

Q37785505-FFF3BA86-52A7-40ED-A72E-3719C111AACE

P577

Q37785505-AA09240F-2230-470B-9715-B6D939EE7DE2

P698

Q37785505-19A6F2E9-D133-4AC7-844F-1074AA7D2EEA

P356

P1433

Medicinal Research Reviews

P1476

Bone metastases: molecular mechanisms and novel therapeutic interventions.

@en

P2093

Athanasios G Papavassiliou

http://www.w3.org/2001/XMLSchema#string

Dionysios J Papachristou

http://www.w3.org/2001/XMLSchema#string

Efthimia K Basdra

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.

Involvement of chemokine receptors in breast cancer metastasis

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES

The role of Src in solid tumors

Latent bone metastasis in breast cancer tied to Src-dependent survival signals

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Gene expression profiling predicts clinical outcome of breast cancer

Wnt/beta-catenin signaling in development and disease

P304

611-636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MED.20224

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20818675

http://www.w3.org/2001/XMLSchema#string